Basel Medical Group BMGL · USD

Health Care · US listing · 🇺🇸 United States

Compare

5.40

+2.08%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SGD, from our data supplier.

FY2025

Revenue

SGD 11.3m

FY2022FY2025

Net income

−SGD 12.1m

FY2022FY2025

Free cash flow

−SGD 4.4m

FY2022FY2025

Shareholders' equity

SGD 4.9m

FY2022FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022
Revenue	SGD 11.3m	SGD 10.1m	SGD 9.7m	SGD 10.7m
Gross profit	SGD 8.8m	SGD 7.8m	SGD 7.4m	SGD 8.5m
Operating income	−SGD 2.2m	SGD 2.2m	SGD 2.0m	SGD 2.5m
Net income	−SGD 12.1m	SGD 2.1m	SGD 1.8m	SGD 2.0m
Diluted earnings per share	-7.72	0.11	0.10	1.26

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022
Total assets	SGD 16.9m	SGD 16.3m	SGD 15.4m	SGD 16.8m
Cash and short-term investments	SGD 3.0m	SGD 2.0m	SGD 1.2m	SGD 1.6m
Total liabilities	SGD 12.0m	SGD 8.7m	SGD 9.9m	SGD 13.1m
Debt	SGD 3.4m	SGD 4.3m	SGD 7.2m	SGD 10.2m
Shareholders' equity	SGD 4.9m	SGD 7.6m	SGD 5.5m	SGD 3.7m
Shares outstanding	2m	18m	19m	2m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022
Cash from operations	−SGD 4.3m	SGD 2.5m	SGD 2.6m	SGD 2.8m
Capital spending	−SGD 54,760	−SGD 7,920	−SGD 6,162	−SGD 88,495
Free cash flow	−SGD 4.4m	SGD 2.5m	SGD 2.6m	SGD 2.7m

Latest quarters

By quarter end

	Mar 2026	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Jun 2024	Dec 2023	Jun 2023
Revenue	SGD 8.2m	SGD 4.2m	SGD 11.3m	SGD 3.2m	SGD 5.0m	SGD 10.1m	SGD 5.1m	SGD 9.7m
Gross profit	−SGD 983,322	SGD 401,612	—	SGD 630,346	—	—	—	—
Operating income	−SGD 2.9m	SGD 399,387	SGD 268,200	SGD 619,808	SGD 472,600	SGD 4.4m	SGD 3.1m	SGD 4.3m
Net income	SGD 268,443	SGD 134,664	−SGD 12.1m	−SGD 5.2m	−SGD 317,000	SGD 2.1m	SGD 1.3m	SGD 1.8m
Diluted earnings per share	0.17	0.09	-0.64	-3.30	-0.02	0.11	0.07	0.10
Cash from operations	−SGD 1.0m	—	—	—	—	—	—	—
Total assets	SGD 20.1m	SGD 20.1m	SGD 18.7m	SGD 18.7m	SGD 14.9m	SGD 16.3m	SGD 16.7m	SGD 15.4m
Cash and short-term investments	SGD 1.3m	SGD 8.4m	—	SGD 9.8m	SGD 7.4m	SGD 2.0m	SGD 943,580	SGD 1.2m
Debt	SGD 3.8m	SGD 3.8m	—	SGD 3.6m	SGD 4.4m	SGD 4.3m	SGD 5.7m	SGD 7.2m
Shareholders' equity	SGD 6.3m	SGD 6.3m	SGD 5.4m	SGD 5.4m	SGD 7.3m	SGD 7.6m	SGD 6.8m	SGD 5.5m

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	2.4%	—	—

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	77.7%	77.7%	—	—

Valuation history

At each fiscal year end

	FY2025
Price to earnings	-0.1
Price to sales	0.1

Share price return

Finished calendar years

	2025
Return	-3%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

12-to-1 reverse split · 22 Jun 2026

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Basel Medical Group BMGL · USD

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Growth per year

Average margins

Valuation history

Share price return

Dividends and splits

Sources and methodology